Your browser doesn't support javascript.
loading
Sex differences among patients with transthyretin amyloid cardiomyopathy - from diagnosis to prognosis.
Patel, Rishi K; Ioannou, Adam; Razvi, Yousuf; Chacko, Liza; Venneri, Lucia; Bandera, Francesco; Knight, Daniel; Kotecha, Tushar; Martinez-Naharro, Ana; Masi, Ambra; Porcari, Aldostefano; Brown, James; Patel, Kiara; Manisty, Charlotte; Moon, James; Rowczenio, Dorota; Gilbertson, Janet A; Sinagra, Gianfranco; Lachmann, Helen; Wechalekar, Ashutosh; Petrie, Aviva; Whelan, Carol; Hawkins, Philip N; Gillmore, Julian D; Fontana, Marianna.
Afiliação
  • Patel RK; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Ioannou A; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Razvi Y; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Chacko L; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Venneri L; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Bandera F; Heart Failure Unit, Cardiology University Department, IRCCS Policlinico San Donato, Milan, Italy.
  • Knight D; Department for Biomedical Sciences for Health, University of Milano, Milan, Italy.
  • Kotecha T; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Martinez-Naharro A; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Masi A; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Porcari A; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Brown J; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Patel K; Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.
  • Manisty C; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Moon J; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Rowczenio D; Barts Heart Centre, The Cardiovascular Magnetic Resonance Imaging Unit, and the Inherited Cardiovascular Diseases Unit, St Bartholomew's Hospital, London, UK.
  • Gilbertson JA; Barts Heart Centre, The Cardiovascular Magnetic Resonance Imaging Unit, and the Inherited Cardiovascular Diseases Unit, St Bartholomew's Hospital, London, UK.
  • Sinagra G; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Lachmann H; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Wechalekar A; Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina (ASUGI), University of Trieste, Trieste, Italy.
  • Petrie A; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Whelan C; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Hawkins PN; Eastman Dental Institute, University College London, London, UK.
  • Gillmore JD; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
  • Fontana M; National Amyloidosis Centre, Division of Medicine, University College London, London, UK.
Eur J Heart Fail ; 24(12): 2355-2363, 2022 12.
Article em En | MEDLINE | ID: mdl-36575133

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropatias Amiloides Familiares / Insuficiência Cardíaca / Cardiomiopatias Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuropatias Amiloides Familiares / Insuficiência Cardíaca / Cardiomiopatias Idioma: En Ano de publicação: 2022 Tipo de documento: Article